Outcomes of concomitant aortic valve procedures and left ventricular assist device implantation: A systematic review and meta-analysis.
Autor: | Iqbal K; Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Arif TB; Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Rathore SS; Department of Internal Medicine, Dr. Sampurnanand Medical College, Jodhpur, India., Ahmed J; Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Kumar P; Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Shahid I; Department of Internal Medicine, Ziauddin Medical University, Karachi, Pakistan., Iqbal A; Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Shariff M; Department of Surgery, Mayo Clinic, Rochester, New York, USA., Kumar A; Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio, USA.; Section of Cardiovascular Research, Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, Akron, Ohio, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Artificial organs [Artif Organs] 2023 Mar; Vol. 47 (3), pp. 470-480. Date of Electronic Publication: 2022 Dec 20. |
DOI: | 10.1111/aor.14482 |
Abstrakt: | Background: Left ventricular assist device (LVAD) implantation is frequently employed in patients with end-stage heart failure. The outcomes of addressing the repair of all substantial aortic valvular disease at the time of LVAD implantation remain unclear. We sought to assess the clinical outcomes in patients undergoing LVAD implantation concomitant with aortic valve procedures (AVPs) compared with isolated LVAD implantation. Methods: A literature search was performed using PubMed, Embase, and Cochrane library from inception till June 2022. Primary outcomes included short-term mortality and long-term survival. Random effects models were used to compute mean differences and odds ratios with 95% confidence intervals (CIs). Results: A total of 14 observational studies (N = 52 693) met our inclusion criteria. Concomitant LVAD implantation and AVPs were associated with higher short-term mortality (OR = 1.61 [95% CI, 1.06-2.42]; p = 0.02) and mean CPBt (MD = 43.25 [95% CI, 22.95-63.56]; p < 0.0001), and reduced long-term survival (OR = 0.70 [95% CI, 0.55-0.88]; p = 0.003) compared with isolated LVAD implantation. No difference in the odds of cerebrovascular accident (OR = 1.05 [95% CI, 0.79-1.39]; p = 0.74) and mean length of hospital stay (MD = 2.89 [95% CI, -4.04 to 9.82]; p = 0.41) was observed between the two groups. On adjusted analysis, short-term mortality was significantly higher in the LVAD group with concurrent AVPs when compared with the isolated LVAD group (aHR = 1.50 [95% CI, 1.20-1.87]; p = 0.0004). Conclusions: Concurrent AVPs were associated with higher short-term mortality and reduced long-term survival in patients undergoing LVAD implantation compared with isolated LVAD implantation. (© 2022 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |